A5051628311- Coronary Interventions and Diagnostics
- Antiplatelet Therapy and Cardiovascular Diseases
- Acute Myocardial Infarction Research
- Peripheral Artery Disease Management
- Cardiac Imaging and Diagnostics
- Vascular Procedures and Complications
- Lipoproteins and Cardiovascular Health
- Cardiac Valve Diseases and Treatments
- Venous Thromboembolism Diagnosis and Management
- Aortic aneurysm repair treatments
- Cerebrovascular and Carotid Artery Diseases
- COVID-19 Clinical Research Studies
- Cardiac, Anesthesia and Surgical Outcomes
- Cardiovascular Disease and Adiposity
- Atrial Fibrillation Management and Outcomes
- Diabetes Treatment and Management
- Long-Term Effects of COVID-19
- Cardiac pacing and defibrillation studies
- Diagnosis and Treatment of Venous Diseases
- Diabetic Foot Ulcer Assessment and Management
- Cardiac and Coronary Surgery Techniques
- COVID-19 and healthcare impacts
- Heart Failure Treatment and Management
- Healthcare Policy and Management
- Mechanical Circulatory Support Devices
Icahn School of Medicine at Mount Sinai
2016-2025
Mount Sinai Hospital
2019-2025
Mount Sinai Hospital
2024
Lenox Hill Hospital
2024
Cardiovascular Institute of the South
2016-2024
Mount Sinai Medical Center
2017-2024
Mount Sinai Hospital
2021
Wilhelminen Hospital
2019
Multilayer in-stent restenosis (ISR) remains a clinical challenge. Intravascular brachytherapy (IVBT) offers "metal-free" treatment modality for multilayer drug-eluting stent (DES)-ISR; however, long-term outcome data on IVBT safety and efficacy are lacking. We sought to compare 3-year outcomes between patients treated with those non-IVBT strategy. Patients DES-ISR (≥2 layers) at Mount Sinai Hospital (2012-2019) were included analysis. The primary was major adverse cardiac events (MACE),...
Drug-coated balloons (DCB) are frequently used to treat femoropopliteal artery disease. However, patency loss occurs in ≥10% of patients within 12 months posttreatment with poor understanding the underlying mechanisms. The authors sought investigate determinants DCB failure Data from randomized clinical trials (IN.PACT SFA, MDT-2113 SFA Japan) and 2 prespecified imaging cohorts IN.PACT Global Clinical Study were included. Influential procedural characteristics evaluated by an independent...
Abstract Background Peripheral artery disease (PAD) is associated with worse outcomes after percutaneous coronary intervention (PCI). The aim of this study was to assess the prognostic impact PAD according high bleeding risk (HBR) status. Methods Consecutive patients undergoing PCI drug‐eluting stent implantation at a tertiary‐care center (Mount Sinai Hospital) between 2012 and 2019 were stratified HBR primary outcome major adverse cardiac events (MACE), composite all‐cause death, myocardial...
Background Patients may prefer percutaneous coronary intervention (PCI) over artery bypass graft (CABG) surgery, despite heart team recommendations. The outcomes in such patients have not been examined. We sought to examine the results of PCI who were recommended for but declined CABG. Methods and Results Consecutive with stable ischemic disease unprotected left main or 3‐vessel Synergy Between Percutaneous Coronary Intervention With Taxus Cardiac Surgery score >22 underwent after review...
Although several variables have been identified as bleeding determinants (BDs), their occurrence and predictive value in patients undergoing percutaneous coronary intervention (PCI) the real world remain unclear. We aimed to characterize rate of BDs PCI with stent implantation a large volume tertiary centre. included stenting at our institution from January 2012 December 2016, defined post-discharge (PDB) requiring hospitalization or transfusion. Several BDs, by PARIS PRECISE-DAPT scores...
Abstract Objectives To investigate the prevalence, predictors and associations between guideline‐directed medical therapy (GDMT) clinical outcomes in acute myocardial infarction (AMI) patients undergoing percutaneous coronary intervention (PCI) from eight academic centers United States. Background Evidence for GDMT with AMI comes randomized controlled trials. The use of practice is unknown this setting. Methods PROMETHEUS a multicenter observational registry comprising 19,914 syndrome (ACS)...
<b><i>Background:</i></b> Data on the associations between serum osmolality (sOsmo) and acute kidney injury (AKI) as well short- long-term mortality in patients with coronary artery disease (CAD) undergoing percutaneous intervention (PCI) are limited. <b><i>Objectives:</i></b> To investigate association sOsmo development of AKI clinical outcomes PCI. <b><i>Methods:</i></b> We investigated 1,927 consecutive PCI from...
Cardiac sarcoidosis (CS) is a rare entity characterized by granulomatous infiltration of the myocardium, which can lead to myocardial fibrosis, conduction abnormalities, and development heart failure, thereby elevating risk sudden cardiac death (SCD). While endomyocardial biopsy (EMBx) regarded as gold standard for diagnosis, its low sensitivity inherent procedural risks may limit practical application.